Metropolitan Life Insurance CO Unity Biotechnology, Inc. Transaction History

Metropolitan Life Insurance CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$2.94 - $12.43 $30,508 - $128,986	-10,377 Closed	0 $0
Q2 2020 Jun 26, 2023	BUY	$5.28 - $9.67 $54,790 - $100,345	10,377 New	10,377 $90,000
Q2 2020 Mar 30, 2023	BUY	$5.28 - $9.67 $54,790 - $100,345	10,377 New	10,377 $90,000
Q2 2020 Aug 14, 2020	BUY	$5.28 - $9.67 $54,790 - $100,345	10,377 New	10,377 $90,000
Q1 2020 Jul 12, 2023	BUY	$5.0 - $7.6 $11,380 - $17,297	2,276 New	2,276 $13.2 Million
Q2 2019 Jul 12, 2023	BUY	$7.59 - $10.21 $17,616 - $23,697	2,321 New	2,321 $22 Million
Q1 2019 May 15, 2019	SELL	$7.65 - $16.66 $67,580 - $147,174	-8,834 Closed	0 $0
Q4 2018 Jul 13, 2023	BUY	$10.76 - $17.25 $95,053 - $152,386	8,834 New	8,834 $143,000
Q4 2018 Feb 14, 2019	BUY	$10.76 - $17.25 $95,053 - $152,386	8,834 New	8,834 $144,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.